Keros Therapeutics is a biotechnology company that is developing drugs to treat a range of diseases, including cancer, inflammation, and metabolic disorders. The company was founded in 2015 and is headquartered in Cambridge, Massachusetts. Keros' products are based on research into the role of certain proteins in the body, and the company is focused on developing drugs that can target these proteins to treat disease. Keros' lead product candidate is a drug for the treatment of anemia, which is currently in clinical trials. The company has partnerships with a number of academic institutions and research organizations, including the University of California, San Francisco and the National Institutes of Health.